Capula Management LTD Danaher Corp Call Options Transaction History

Capula Management LTD

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$239.25 - $280.76 $47,850 - $56,152	-200 Reduced 15.38%	1,100 $305,000
Q2 2024 Aug 05, 2024	BUY	$235.51 - $267.98 $306,163 - $348,374	1,300 New	1,300 $324,000
Q3 2023 Nov 03, 2023	BUY	$233.08 - $265.59 $559,392 - $637,415	2,400 New	2,400 $595,000
Q1 2023 May 10, 2023	BUY	$239.75 - $277.0 $7.19 Million - $8.31 Million	30,000 Added 111.94%	56,800 $14.3 Million
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $1.88 Million - $2.2 Million	-7,800 Reduced 22.54%	26,800 $7.11 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $8.55 Million - $52.2 Million	34,600 New	34,600 $8.94 Million
Q1 2022 May 17, 2022	BUY	$257.27 - $315.76 $7.18 Million - $8.81 Million	27,900 New	27,900 $8.18 Million
Q4 2021 Feb 14, 2022	SELL	$292.08 - $329.01 $7.48 Million - $8.42 Million	-25,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $6.97 Million - $8.51 Million	25,600 New	25,600 $7.79 Million

2,511

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.